Pentastarch in a balanced solution reduces hepatic leukocyte recruitment in early sepsis

Microcirculation. 2004 Dec;11(8):679-87. doi: 10.1080/10739680490517712.

Abstract

Objective: To characterize the hepatic leukocyte endothelial cell interactions occurring in early sepsis and to determine whether this is influenced by fluid treatment.

Methods: Sepsis was induced by cecal ligation and perforation in C57Bl/6 mice. One of 6 iv fluid regimes was given immediately postsurgery and at 6 h. The hepatic microcirculation was examined by intravital microscopy at 6 h.

Results: All 0.9% saline-based solutions were associated with an increase in leukocyte-endothelial cell interactions as demonstrated by an increase in the rolling flux in the sham and naïve mice. In the septic mice treated with normal saline, there was a 20-fold increase in leukocyte adhesion within the postsinusoidal venules, compared to sham mice. Treatment with lactated Ringer's reduced the sepsis-mediated leukocyte recruitment by 50%. When septic mice received 6% pentastarch in a balanced solution or 3% saline, venular leukocyte adhesion was reduced by an additional 50%. When the pentastarch was prepared in normal saline there was no further reduction in venular leukocyte adhesion compared to the lactated Ringer's-treated mice. All hyperosmolar solutions improved the sepsis-induced reduction in sinusoidal perfusion but only the pentastarch in the balance solution significantly reduced the number of adherent leukocytes within the sinusoids.

Conclusions: Hepatic leukocyte recruitment occurs early in sepsis. Pentastarch in a balanced solution but not in normal saline significantly reduces hepatic leukocyte recruitment, suggesting solution composition, as well as osmolarity impact the innate immune response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Communication / drug effects
  • Chemotaxis, Leukocyte / drug effects*
  • Disease Models, Animal
  • Endothelium, Vascular / pathology
  • Hydroxyethyl Starch Derivatives / therapeutic use*
  • Isotonic Solutions / therapeutic use
  • Liver / blood supply
  • Liver / pathology*
  • Liver Circulation
  • Mice
  • Mice, Inbred C57BL
  • Microcirculation
  • Microscopy, Video
  • Plasma Substitutes / therapeutic use
  • Sepsis / drug therapy*
  • Sepsis / pathology
  • Time

Substances

  • Hydroxyethyl Starch Derivatives
  • Isotonic Solutions
  • Plasma Substitutes